PepGen Ltd (PEPG)

NASDAQ
10.36
+0.15(+1.47%)
  • Volume:
    16,856
  • Day's Range:
    9.99 - 10.63
  • 52 wk Range:
    7.82 - 16.99

PEPG Overview

Prev. Close
10.21
Day's Range
9.99-10.63
Revenue
-
Open
10.14
52 wk Range
7.82-16.99
EPS
-1.22
Volume
16,856
Market Cap
241.28M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
171,487
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
23,631,924
Next Earnings Date
Aug 31, 2022
What is your sentiment on PepGen?
or
Vote to see community's results!

PepGen Ltd News

  • PepGen IPO Gains on Open, Trends Back to IPO Price
    • ByInvesting.com-

    Today's IPO for PepGen, Inc (PEPG) opened for trading earlier today at $15.60 per share after pricing 9,000,000 shares of common stock at $12. Shares have since fell back to...

PepGen Ltd Analysis

PepGen Ltd Company Profile

PepGen Ltd Company Profile

Employees
31

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company’s lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellNeutral
Technical IndicatorsStrong SellStrong SellStrong BuyStrong SellStrong Buy
SummaryStrong SellStrong SellNeutralStrong SellBuy